Pharmacological profile of ramosetron, a novel therapeutic agent for IBS

Author： Hirata T.   Funatsu T.   Keto Y.   Nakata M.   Sasamata M.  

Publisher： Springer Publishing Company

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.15, Iss.1, 2007-02, pp. : 5-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The in vitro pharmacological profile of prucalopride, a novel enterokinetic compound

By Briejer M.R.   Bosmans J.-P.   Van Daele P.   Jurzak M.   Heylen L.   Leysen J.E.   Prins N.H.   Schuurkes J.A.J.  

European Journal of Pharmacology, Vol. 423, Iss. 1, 2001-06 ,pp. : 71-83

Elsevier

Access to resources Recommend Favorite

Novel pharmacological modulators of autophagy and therapeutic prospects

By Bischoff Pierre   Josset Elodie   Dumont Francis J  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 9, 2012-09 ,pp. : 1053-1079

Informa Healthcare

Access to resources Recommend Favorite

Pharmacology and Metabolism of Renzapride: A Novel Therapeutic Agent for the

By Meyers Nicholas L.   Hickling Roger I.  

Drugs in R&D, Vol. 9, Iss. 1, 2008-01 ,pp. : 37-63

Adis International

Access to resources Recommend Favorite

Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative

By Shibata T.   Matsui K.   Nagao K.   Shinkai H.   Yonemori F.   Wakitani K.  

European Journal of Pharmacology, Vol. 364, Iss. 2, 1999-01 ,pp. : 211-219

Elsevier

Access to resources Recommend Favorite

Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist

By Shibasaki M.   Fujimori A.   Takanashi M.   Kusayama T.   Tokioka T.   Satoh Y.   Okazaki T.   Uchida W.   Inagaki O.   Yanagisawa I.  

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 167-173

Elsevier

Access to resources Recommend Favorite